Adults with persistent acne can compare antiandrogen treatments by how they are taken, how well they work, and what risks they carry. The main options for adult women are combined estrogen-progestin pills, oral spironolactone, and clascoterone 1% cream. Antiandrogens are medicines that block the action of androgens, male-type hormones that raise sebum and drive breakouts. They suit a different pattern than short courses of antibiotics and standard creams.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who fits the hormonal pattern?
- How do birth-control pills help acne?
- What does oral spironolactone offer?
- What makes clascoterone cream different?
- How do safety and practical choices compare?
Who fits the hormonal pattern?
Adult women with persistent acne often get lesions along the lower face, jawline, and upper neck. Flares commonly worsen before periods and respond poorly to antibiotics and traditional therapy, according to Northwestern dermatologists via Newswise. That pattern points toward hormonal evaluation.
Evaluation does not mean every breakout needs hormones. It means location, timing, and treatment history help a clinician decide whether to test an antiandrogen approach. Bring notes on cycle flares, past antibiotics, and current contraception to the visit.
How do birth-control pills help acne?
Combined estrogen-progestin contraceptives lower free androgens by raising sex-hormone-binding globulin and curbing ovarian androgen output. Ortho Tri-Cyclen, Estrostep, and Yaz/Beyaz are FDA-approved for acne in women who also want contraception.
A comprehensive review in Dermatology and Therapy found different combined formulations have comparable acne benefit, so choice often rests on contraceptive needs and tolerability the Springer review. Pills require daily use and cardiovascular screening. Candidates need review for smoking, hypertension, migraine with aura, clot history, and drospirenone-containing products because clot, stroke, and heart-attack risk is highest in the first year, as summarized by Optum Perks from FDA data the Optum Perks summary.
What does oral spironolactone offer?
Oral spironolactone blocks androgen receptors and aldosterone, which lowers sebum. Clinicians use it off-label for moderate-to-severe adult female acne, often starting at 25-50 mg daily and rising to 100 mg daily, alone or with a contraceptive.
Reported efficacy ranges from 33%-85%, and the same Dermatology and Therapy review described spironolactone as effective first-line therapy for women. Response builds over months rather than days. Regular follow-up helps set dose, check blood pressure, and track periods.
- Period changes affect 15%-30% of users
- Avoid use in pregnancy because of risk to male fetal development
- Potassium rise is rare in healthy young women but climbs after age 46, with kidney disease, or with ACE-inhibitor use
What makes clascoterone cream different?
Clascoterone 1% cream, sold as Winlevi, is a first-in-class topical androgen-receptor inhibitor applied as a thin layer twice daily. It acts mainly in skin with limited absorption into the bloodstream, according to the FDA approval history on Drugs.com. Regulators approved it in August 2020 for acne vulgaris in patients 12 years and older.
That local action matters for adults who cannot take systemic hormones. The Dermatology and Therapy review found clascoterone safe and effective for men and women with fewer reproductive-hormone effects than systemic agents. It also avoids daily pills and does not provide contraception.
How do safety and practical choices compare?
Systemic choices trade stronger hormonal effects for systemic risks. Combined pills demand clot and blood-pressure screening. Spironolactone mainly causes transient breast tenderness, dizziness, and period irregularity, plus the pregnancy and potassium cautions above.
Clascoterone mainly causes local redness, dryness, and itching that often fade. Human pregnancy safety data are lacking, so anyone pregnant, planning pregnancy, or breastfeeding should discuss timing with a clinician. Compounded topical spironolactone is not a substitute because it remains off-label without regulatory approval, unlike clascoterone which drew support from two phase 3 trials plus long-term studies totaling over 1,700 patients. Ask your clinician which route fits your acne pattern, contraceptive needs, pregnancy plans, and heart and kidney risks.
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: How Adults With Persistent Acne Can Compare Treatment Options
- Limited Topical Spironolactone Evidence in the 2026 Review: How Adults With Persistent Acne Can Compare Treatment Options
- Topical Clascoterone Evidence Revisited in 2026: How Adults With Persistent Acne Can Compare Treatment Options